Dr. McCracken is the principal investigator of the National Institute of Mental Health (NIMH) Research Center, "Translational Research to Enhance Cognitive Control," which aims to develop and test innovative treatments for cognitive defects associated with child psychiatric illness. Other current areas of research in the McCracken lab include genetic studies of

  1. Childhood disorders including attention-deficit/hyperactivity disorder (ADHD), autism, obsessive-compulsive disorder, and anxiety disorders;
  2. The integration of neuroimaging with genetics to investigate addiction and substance abuse phenotypes;
  3. Treatment response and adverse effects (pharmacogenomics) in autism, depression, and anxiety in both adults and children.

We enjoy teaching and working with undergraduate, graduate, and medical students, postdocs, and medical residents and fellows.